{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T18:20:50Z","timestamp":1789842050561,"version":"4.0.1"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Carlos III Health Institute","doi-asserted-by":"publisher","award":["PI20\/01446"],"award-info":[{"award-number":["PI20\/01446"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.msard.2026.107319","type":"journal-article","created":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T00:16:14Z","timestamp":1781136974000},"page":"107319","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Tear CHI3L1 in multiple sclerosis: a non-invasive biomarker linked to disease progression"],"prefix":"10.1016","volume":"112","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-4578-8406","authenticated-orcid":false,"given":"J\u00e9ssica","family":"Castillo-Villalba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6262-7499","authenticated-orcid":false,"given":"Raquel","family":"Gasque-Rubio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-9824-5076","authenticated-orcid":false,"given":"Lorena","family":"For\u00e9s-Toribio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4622-2173","authenticated-orcid":false,"given":"Jordi","family":"Tortosa-Carreres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0596-5613","authenticated-orcid":false,"given":"Gemma","family":"Garc\u00eda-Lluch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Ferrer-Pardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0021-3041","authenticated-orcid":false,"given":"Sara","family":"Carratal\u00e1-Bosc\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4799-7579","authenticated-orcid":false,"given":"Carmen","family":"Alcal\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Gorriz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4681-2456","authenticated-orcid":false,"given":"Carlos","family":"Quintanilla-Bord\u00e1s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3117-4743","authenticated-orcid":false,"given":"Javier","family":"Poyatos-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3806-925X","authenticated-orcid":false,"given":"Bonaventura","family":"Casanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4934-3891","authenticated-orcid":false,"given":"Laura","family":"Cubas-N\u00fa\u00f1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3767-3738","authenticated-orcid":false,"given":"Francisco","family":"P\u00e9rez-Miralles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.msard.2026.107319_bib0001","doi-asserted-by":"crossref","DOI":"10.1001\/jamaneurol.2023.3997","article-title":"Neurofilament light chain elevation and disability progression in multiple sclerosis","author":"Abdelhak","year":"2023","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.msard.2026.107319_bib0002","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-018-33158-8","article-title":"Serum GFAP as a biomarker for disease severity in multiple sclerosis","volume":"8","author":"Abdelhak","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.msard.2026.107319_bib0003","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-67934-2","article-title":"Serum GFAP in multiple sclerosis: correlation with disease type and MRI markers of disease severity","volume":"10","author":"Ayrignac","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.msard.2026.107319_bib0004","article-title":"The peripheral profile of the chitinase 3-like-1 in benign multiple sclerosis - a single centre\u2019s experience","author":"Barcutean","year":"2023","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10.1016\/j.msard.2026.107319_bib0005","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.parkreldis.2019.03.001","article-title":"Proteomic analysis of tear fluid reveals disease-specific patterns in patients with Parkinson\u2019s disease - a pilot study","volume":"63","author":"Boerger","year":"2019","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.msard.2026.107319_bib0006","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1111\/j.1750-3639.2011.00550.x","article-title":"Astrocyte and macrophage regulation of YKL-40 expression and cellular response in neuroinflammation","volume":"22","author":"Bonneh-Barkay","year":"2012","journal-title":"Brain Pathol."},{"key":"10.1016\/j.msard.2026.107319_bib0007","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1742-2094-7-34","article-title":"In vivo CHI3L1 (YKL-40) expression in astrocytes in acute and chronic neurological diseases","volume":"7","author":"Bonneh-Barkay","year":"2010","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.msard.2026.107319_bib0008","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1177\/1352458509352195","article-title":"Tear analysis in clinically isolated syndrome as new multiple sclerosis criterion","volume":"16","author":"Calais","year":"2010","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2026.107319_bib0009","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1177\/1352458511433063","article-title":"Chitinase 3-like 1 plasma levels are increased in patients with progressive forms of multiple sclerosis","volume":"18","author":"Canto","year":"2012","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2026.107319_bib0010","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1093\/brain\/awv017","article-title":"Chitinase 3-like 1: prognostic biomarker in clinically isolated syndromes","volume":"138","author":"Canto","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.msard.2026.107319_bib0011","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.neulet.2013.08.019","article-title":"Tear levels of tumor necrosis factor-alpha in patients with Parkinson\u2019s disease","volume":"553","author":"\u00c7omo\u011flu","year":"2013","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.msard.2026.107319_bib0012","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000972","article-title":"Potential Role of CHI3L1+ Astrocytes in Progression in MS","volume":"8","author":"Cubas-N\u00fa\u00f1ez","year":"2021","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.msard.2026.107319_bib0013","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.preteyeres.2009.04.003","article-title":"Neural regulation of lacrimal gland secretory processes: relevance in dry eye diseases","volume":"28","author":"Dartt","year":"2009","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.msard.2026.107319_bib0014","doi-asserted-by":"crossref","unstructured":"Enache, I.I., Tiu, V.E., Anghel, A., Tiu, C., Popa-cherecheanu, A., Bostan, M., Scippa, S., Balestrieri, A., Smaldone, G., Soricelli, A., 2025. GFAP , CHI3L1 and GCIPL thickness as baseline predictors of early disability progression in MS 1\u201311.","DOI":"10.3390\/ijms262411774"},{"key":"10.1016\/j.msard.2026.107319_bib0015","first-page":"410","article-title":"Serum biomarker levels predict disability progression in patients with primary progressive multiple sclerosis","volume":"95","author":"Fissolo","year":"2024","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.msard.2026.107319_bib0016","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000001164","article-title":"Role of chitinase 3-like 1 as a biomarker in multiple sclerosis: a systematic review and meta-analysis","volume":"9","author":"Floro","year":"2022","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.msard.2026.107319_bib0017","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.3389\/fneur.2019.01008","article-title":"Combined cerebrospinal fluid neurofilament light chain protein and chitinase-3 like-1 levels in defining disease course and prognosis in multiple sclerosis","volume":"10","author":"Gil-Perotin","year":"2019","journal-title":"Front. Neurol."},{"key":"10.1016\/j.msard.2026.107319_bib0018","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1177\/1352458514561906","article-title":"Chitinase 3-like proteins as diagnostic and prognostic biomarkers of multiple sclerosis","volume":"21","author":"Hinsinger","year":"2015","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2026.107319_bib0019","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.3389\/fimmu.2019.01110","article-title":"Investigation of oligoclonal igg bands in tear fluid of multiple sclerosis patients","volume":"10","author":"H\u00fcmmert","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.msard.2026.107319_bib0020","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0158000","article-title":"Changes in the chemical barrier composition of tears in Alzheimer\u2019s disease reveal potential tear diagnostic biomarkers","volume":"11","author":"Kall\u00f3","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.msard.2026.107319_bib0021","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-51837-y","article-title":"Proteins and microRNAs are differentially expressed in tear fluid from patients with Alzheimer\u2019s disease","volume":"9","author":"Kenny","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.msard.2026.107319_bib0022","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.neurol.2014.11.007","article-title":"Tear analysis as a tool to detect oligoclonal bands in radiologically isolated syndrome","volume":"171","author":"Lebrun","year":"2015","journal-title":"Rev. Neurol."},{"key":"10.1016\/j.msard.2026.107319_bib0023","doi-asserted-by":"crossref","DOI":"10.3390\/cells13080678","article-title":"Recently updated role of chitinase 3-like 1 on various cell types as a major influencer of chronic inflammation","volume":"13","author":"Mizoguchi","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.msard.2026.107319_bib0024","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000815","article-title":"CSF chitinase 3-like-1 association with disability of primary progressive MS","volume":"7","author":"P\u00e9rez-Miralles","year":"2020","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.msard.2026.107319_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.jprot.2019.103403","article-title":"Proteomics characterization of extracellular vesicles sorted by flow cytometry reveals a disease-specific molecular cross-talk from cerebrospinal fluid and tears in multiple sclerosis","volume":"204","author":"Pieragostino","year":"2019","journal-title":"J. Proteomics"},{"key":"10.1016\/j.msard.2026.107319_bib0026","first-page":"137","article-title":"Schirmer strip vs. capillary tube method: non-invasive methods of obtaining proteins from tear fluid","volume":"195","author":"Posa","year":"2013","journal-title":"Ann. Anat. = Anat. Anzeiger Off. organ Anat. Gesellschaft"},{"key":"10.1016\/j.msard.2026.107319_bib0027","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1111\/ene.13687","article-title":"Cognitive impairment in early stages of multiple sclerosis is associated with high cerebrospinal fluid levels of chitinase 3-like 1 and neurofilament light chain","volume":"25","author":"Quintana","year":"2018","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.msard.2026.107319_bib0028","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/prca.201300053","article-title":"Exploring the human tear fluid: discovery of new biomarkers in multiple sclerosis","volume":"8","author":"Salvisberg","year":"2014","journal-title":"Proteomics. Clin. Appl."},{"key":"10.1016\/j.msard.2026.107319_bib0029","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1016\/j.ophtha.2005.04.025","article-title":"Tear film tests in Parkinson\u2019s disease patients","volume":"112","author":"Tamer","year":"2005","journal-title":"Ophthalmology"},{"key":"10.1016\/j.msard.2026.107319_bib0030","unstructured":"Vercellin, A.V., Isserow, L.J., Rosen, R.B., Sidoti, P.A., Siesky, B.A., Wood, K., Schanzer, N., Oddone, F., Carnevale, C., Yee, T., Tai, T., Chen, M., Manusis, K., Tai, K., Brenner, D.J., Kleiman, N.J., Potash, S., Eckert, G.J., Antman, G., 2025. The effects of age on the human tear film assessed with a novel imaging device 1\u20139."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221103482600355X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221103482600355X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T20:58:00Z","timestamp":1786481880000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221103482600355X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":30,"alternative-id":["S221103482600355X"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2026.107319","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tear CHI3L1 in multiple sclerosis: a non-invasive biomarker linked to disease progression","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2026.107319","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107319"}}